Cinven, Hg fined £60M+ over Advanz drug pricing
July 29, 2021
The UK's competition watchdog has fined drug company Advanz, along with its previous private equity backers Cinven and Hg, a total of over £100 million after the company hiked the price of its thyroid tablet by 6,000% in about 10 years.